"Lento Bio's innovative approach to treating the underlying cause of presbyopia would, if approved, broaden the therapeutic options for the most common refractive condition, impacting billions of ...

Please provide your email address to receive an email when new articles are posted on . Staff can be trained to collect information about patients’ lifestyles from ...

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...

Sarah Jessica Parker fronts LENZ Therapeutics’ “Make It VIZZable” campaign, raising awareness of presbyopia and spotlighting ...